Companies in the Services sector have received a lot of coverage today as analysts weigh in on Madison Square Garden Co (MSG), Quest Diagnostics Inc (DGX) and Dollar Tree (DLTR).
Madison Square Garden Co (MSG)
In a report released today, Benjamin Swinburne from Morgan Stanley maintained a Hold rating on Madison Square Garden Co, with a price target of $310. The company’s shares closed yesterday at $272.21.
According to TipRanks.com, Swinburne is a 5-star analyst with an average return of 11.1% and a 58.7% success rate. Swinburne covers the Services sector, focusing on stocks such as Interpublic Group of Companies, Cinemark Holdings Inc, and MSG Networks Inc.
Madison Square Garden Co has an analyst consensus of Moderate Buy, with a price target consensus of $349.33.
See today’s analyst top recommended stocks >>
Quest Diagnostics Inc (DGX)
Morgan Stanley analyst Ricky Goldwasser maintained a Buy rating on Quest Diagnostics Inc today and set a price target of $107. The company’s shares closed yesterday at $87.94, close to its 52-week low of $87.40.
According to TipRanks.com, Goldwasser is a 3-star analyst with an average return of 3.2% and a 56.9% success rate. Goldwasser covers the Services sector, focusing on stocks such as Charles River Labs, Laboratory Corp, and CVS Health.
Currently, the analyst consensus on Quest Diagnostics Inc is a Moderate Buy with an average price target of $105.93, a 20.5% upside from current levels. In a report released yesterday, Credit Suisse also maintained a Buy rating on the stock with a $103 price target.
.
Dollar Tree (DLTR)
Credit Suisse analyst Judah Frommer maintained a Buy rating on Dollar Tree today and set a price target of $97. The company’s shares closed yesterday at $88.43.
According to TipRanks.com, Frommer is a 3-star analyst with an average return of 4.3% and a 77.3% success rate. Frommer covers the Services sector, focusing on stocks such as Ollie’s Bargain Outlet Holding, Sprouts Farmers, and Dollar General.
Dollar Tree has an analyst consensus of Moderate Buy, with a price target consensus of $95.15, a 7.6% upside from current levels. In a report released yesterday, Oppenheimer also assigned a Buy rating to the stock with a $92 price target.
.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
